Quote:
Originally Posted by BMEP100
Last year I became aware of that stuff, when a resolution came to the floor of our state political convention concerning it, from a lady I’ve know for decades, in our church. She suffers from severe hip and back pain as well as fibromyalgia. She had been on oxy...something for years and was trying to get weaned off. According to her, she’s been off the pain meds now for 6months has no issues with the fibromyalgia or anxiety. She takes that stuff 3 times a day, at a cost of about 3 dollars/day.
Needless to say she is a huge advocate. The more studies I read,the more I am convinced it is the next “aspirin”.
I’ve always been skeptical of the influence of big pharma on the FDA. Reading the actual science on it has made me an advocate.
However, I don’t think it would be a good idea to fly with it. You can read the studies for yourself here: American Kratom Association - Science
And I think you are a naive fool:
Aggarwal, Geeta et al. “Death from Kratom toxicity and the possible role of intralipid.” Journal of the Intensive Care Society vol. 19,1 (2017): 61-63. doi:10.1177/1751143717712652
Death from Kratom toxicity and the possible role of intralipid
Geeta Aggarwal, Edward Robertson, [...], and Edward Walter
Additional article information
Abstract
We present the case of a 26-year-old man who was brought into our emergency department in cardiorespiratory arrest, having taken Kratom 24 h previously. Despite multi-organ support, he deteriorated and died from cardiorespiratory failure and hypoxic brain damage 12 h later. Lipid emulsion was given, with significant temporary improvement in the cardiorespiratory failure. Kratom is derived from Mitragyna speciosa, a tropical deciduous and evergreen tree in the coffee family, and is native to Southeast Asia, and its leaves are used as a legal high in some parts of the world. Here, we review the pharmacochemistry of the drug, and wish to highlight that the effects of Kratom may not be as benign as are commonly reported, and the possible role of intralipid in managing the Kratom toxicity in this case.
......
Morbidity and Mortality Weekly Report (MMWR)
CDC
Facebook Twitter Email Syndicate
Notes from the Field: Unintentional Drug Overdose Deaths with Kratom Detected — 27 States, July 2016–December 2017
Weekly / April 12, 2019 / 68(14);326–327
Emily O’Malley Olsen, PhD1; Julie O’Donnell, PhD1; Christine L. Mattson, PhD1; Joshua G. Schier, MD1; Nana Wilson, PhD1 (View author affiliations)
View suggested citation
Article Metrics
Altmetric:
Article has an altmetric score of 291
Metric Details
Table
References
Related Materials
Cdc-pdf
Kratom (Mitragyna speciosa), a plant native to Southeast Asia, contains the alkaloid mitragynine, which can produce stimulant effects in low doses and some opioid-like effects at higher doses when consumed (1). Use of kratom has recently increased in popularity in the United States, where it is usually marketed as a dietary or herbal supplement (1). Some studies suggest kratom has potential for dependence and abuse (1,2). As of April 2019, kratom was not scheduled as a controlled substance. However, since 2012, the Food and Drug Administration has taken a number of actions related to kratom, and in November 2017 issued a public health advisory*; in addition, the Drug Enforcement Administration has identified kratom as a drug of concern. During 2011–2017, the national poison center reporting database documented 1,807 calls concerning reported exposure to kratom (3). To assess the impact of kratom, CDC analyzed data from the State Unintentional Drug Overdose Reporting System (SUDORS)
....
Among the known side effects of this “herbal supplement” is seizures. You can play “bet your wings” all you want, but the risk of kidney or liver damage is high, and even one seizure and it is unlikely you will ever again fly legally as a commercial pilot.